425 related articles for article (PubMed ID: 21644813)
1. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.
Hutson CB; Lazo CR; Mortazavi F; Giza CC; Hovda D; Chesselet MF
J Neurotrauma; 2011 Sep; 28(9):1783-801. PubMed ID: 21644813
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
3. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
McCormack AL; Thiruchelvam M; Manning-Bog AB; Thiffault C; Langston JW; Cory-Slechta DA; Di Monte DA
Neurobiol Dis; 2002 Jul; 10(2):119-27. PubMed ID: 12127150
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury.
Liu M; Bachstetter AD; Cass WA; Lifshitz J; Bing G
J Neurotrauma; 2017 Jan; 34(2):414-422. PubMed ID: 27142118
[TBL] [Abstract][Full Text] [Related]
5. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.
Thiruchelvam M; McCormack A; Richfield EK; Baggs RB; Tank AW; Di Monte DA; Cory-Slechta DA
Eur J Neurosci; 2003 Aug; 18(3):589-600. PubMed ID: 12911755
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
[TBL] [Abstract][Full Text] [Related]
8. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
9. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
Ossowska K; Wardas J; Smiałowska M; Kuter K; Lenda T; Wierońska JM; Zieba B; Nowak P; Dabrowska J; Bortel A; Kwieciński A; Wolfarth S
Eur J Neurosci; 2005 Sep; 22(6):1294-304. PubMed ID: 16190885
[TBL] [Abstract][Full Text] [Related]
10. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
[TBL] [Abstract][Full Text] [Related]
11. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
[TBL] [Abstract][Full Text] [Related]
12. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
Ossowska K; Smiałowska M; Kuter K; Wierońska J; Zieba B; Wardas J; Nowak P; Dabrowska J; Bortel A; Biedka I; Schulze G; Rommelspacher H
Neuroscience; 2006 Sep; 141(4):2155-65. PubMed ID: 16797138
[TBL] [Abstract][Full Text] [Related]
13. Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy.
Suárez I; Bodega G; Rubio M; Fernández B
Restor Neurol Neurosci; 2017; 35(5):469-481. PubMed ID: 28984618
[TBL] [Abstract][Full Text] [Related]
14. Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs.
Khwaja M; McCormack A; McIntosh JM; Di Monte DA; Quik M
J Neurochem; 2007 Jan; 100(1):180-90. PubMed ID: 17227438
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
[TBL] [Abstract][Full Text] [Related]
16. Influence of paraquat on dopaminergic transporter in the rat brain.
Ossowska K; Wardas J; Kuter K; Nowak P; Dabrowska J; Bortel A; Labus Ł; Kwieciński A; Krygowska-Wajs A; Wolfarth S
Pharmacol Rep; 2005; 57(3):330-5. PubMed ID: 15985715
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
[TBL] [Abstract][Full Text] [Related]
20. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
